Rhonexum, a quantum technology startup, has secured $1 million in pre-seed funding, led by QDNL Participations, with participation from Venture Kick, alongside additional grant support from Swiss innovation programs.
Rhonexum, a quantum technology startup, has secured $1 million in pre-seed funding, led by QDNL Participations, with participation from Venture Kick, alongside additional grant support from Swiss innovation programs.
Seprify, a biomaterials company headquartered in Fribourg, Switzerland, has secured €13.4 million (CHF 12.25 million) in Series A funding to scale production of its cellulose-based ingredients for industrial applications.
Polares Medical, a clinical-stage medical technology company headquartered in Lausanne, Switzerland, has raised $50 million in a Series C funding round to support the development of its transcatheter therapy for mitral regurgitation.
Alithea Genomics, a transcriptomics technology company based in Lausanne, has completed a CHF 6.9 million seed funding round to expand the commercialization of its RNA sequencing tools used in drug discovery and biological research.
Geneva-based Clee Medical has closed its Seed financing round to accelerate the development of its real-time intraoperative brain imaging platform, Neuro Access.
START Summit 2026 will once again bring together Europe’s entrepreneurial ecosystem in St. Gallen, positioning itself as one of the continent’s leading early-stage conferences at the intersection of technology and entrepreneurship.
CLIMATEX AG, a Swiss textile technology company focused on circular material innovation, has secured €3.5 million (CHF 3.2 million) in a financing round led by the Collateral Good Textile & Fashion Innovation Fund, with additional participation from existing investors.
Rapidata, a Zurich-based AI infrastructure startup, has raised $8.5 million in Seed funding to expand its human feedback network for AI model development.
Zurich-based ScyAI has raised €2 million in a pre-seed funding round led by AENU and co-led by PT1, with additional backing from founders and angel investors, including David Helgason, Maex Ament, Philip Stehlik through Anti Ordinary Ventures, as well as Bela Lainck, Robert Levenhagen, Christoph Aufmhof, and Stefanie Gerhart via
